London, UK, 24 September 2007, Curidium Medica plc, (LSE:CUR.L - News) the personalized medicine company focused on bringing the right drug to the right patient, today announced that it will be presenting at the 2007 UBS Global Life Sciences Conferences in New York, New York, USA. Gosse B. Bruinsma, Executive Chairman, will be presenting the current status of the Company and its strategic business objectives. The presentation is scheduled at 1:00 pm local time on Thursday, 27 September 2007 in the Grand Hyatt Hotel. The presentation will be webcast and accessible remotely by persons wishing to follow the presentation live and will be archived for 30 days on the Company’s website; for access please visit: www.ibb.ubs.com.
